Combination of Plasma Pharmacochemistry, RNA-Seq, and Molecular Docking Strategies to Reveal the Mechanism of the Alkaloid Fraction of Nelumbinis folium for the Treatment of Hyperlipidemia
Molecules · 2025
DOI: 10.3390/molecules30183727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Yuan Cai und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Hyperlipidemias, Alkaloids, Nelumbo. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Beijing, China, Natural Science Foundation of Beijing.
Abstract (Originalsprache)
Nelumbinis folium (N. folium) exhibits hypolipidemic effects and shows great potential for application in lipid-lowering drugs and healthcare products. This study aimed to investigate the mechanism underlying the hypolipidemic effects of the alkaloid fraction of N. folium (AFN). Animal experiments demonstrated that AFN significantly reduced blood lipid levels and ameliorated liver damage in hyperlipidemic mice. RNA-seq analysis identified 26 reverse-regulated differentially expressed genes (DEGs), which were primarily involved in the PPAR signaling pathway, fat digestion and absorption, and fatty acid degradation. Using UPLC-MSn, 30 plasma-absorbed components were identified, including 13 prototype alkaloids. Among these, three key active components—nuciferine, N-nornuciferine, and N-methylisococlaurine—were screened via network topology analysis. Molecular docking revealed strong binding affinities between these compounds and key targets. The results showed that N-methylisococlaurine bound to SLC27A4 and CPT1A with strong affinity, while nuciferine and N-nornuciferine bound to ACADVL and PPARA. RT-qPCR results confirmed that AFN modulates the expression of FABP1, SLC27A4, PPARA, CPT1A, ACAA2, APOC3, and APOA4. These findings suggest that AFN exerts its hypolipidemic effects through multi-component, multi-target, and multi-pathway mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
ORCID-Profile: Shifen Dong
Förderung
- Natural Science Foundation of Beijing, China
- Natural Science Foundation of Beijing
Zitieren
APA
Cai, Y., Huang, R., Lin, T., Yang, L., Zhou, C., Li, Y., Liu, B., Dong, S., & Jiang, Y. (2025). Combination of Plasma Pharmacochemistry, RNA-Seq, and Molecular Docking Strategies to Reveal the Mechanism of the Alkaloid Fraction of Nelumbinis folium for the Treatment of Hyperlipidemia. Molecules. https://doi.org/10.3390/molecules30183727
Vancouver
Cai Y, Huang R, Lin T, Yang L, Zhou C, Li Y, et al. Combination of Plasma Pharmacochemistry, RNA-Seq, and Molecular Docking Strategies to Reveal the Mechanism of the Alkaloid Fraction of Nelumbinis folium for the Treatment of Hyperlipidemia. Molecules. 2025. doi:10.3390/molecules30183727
BibTeX
@article{Cai2025,
author = {Cai, Yuan and Huang, Rong and Lin, Tianfeng and Yang, Leyi and Zhou, Chang and Li, Yumiao and Liu, Bin and Dong, Shifen and Jiang, Yanyan},
title = {Combination of Plasma Pharmacochemistry, RNA-Seq, and Molecular Docking Strategies to Reveal the Mechanism of the Alkaloid Fraction of Nelumbinis folium for the Treatment of Hyperlipidemia},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30183727}
}
EUVIMED